Evaluation of HOXB13 as a molecular marker of recurrent prostate cancer

Many patients with prostate cancer have disease recurrence following surgical removal of tumors and fail to respond to androgen ablation therapy. Despite the existence of a number of clinical/pathological factors, it is not possible to predict which patients will fall into this category. The results...

Descripción completa

Detalles Bibliográficos
Autores principales: JEONG, TAE-O, OH, KYUNG-JIN, NGUYEN, NGUYEN THI XUAN, KIM, YOUNG-RANG, KIM, MIN SOO, LEE, SANG DON, RYU, SOO BANG, JUNG, CHAEYONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493085/
https://www.ncbi.nlm.nih.gov/pubmed/22293681
http://dx.doi.org/10.3892/mmr.2012.769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493085/
https://www.ncbi.nlm.nih.gov/pubmed/22293681
http://dx.doi.org/10.3892/mmr.2012.769

Ejemplares similares